Early use of antiretroviral therapy in HIV is best
This article was originally published in Scrip
HIV patients should be treated with antiretroviral therapy as early as possible, even if they are asymptomatic, concludes two studies, one published online in the New England Journal of Medicine (NEJM) on April 1st, and the other in The Lancet, published online on April 9th.
You may also be interested in...
Somaxon Pharmaceuticals and Procter & Gamble Pharmaceuticals are to co-promote Somaxon's insomnia drug Silenor (low-dose doxepin) in the US.
GlaxoSmithKline has begun the Phase III clinical trials programme for its adjuvanted vaccine candidate (GSK1437173A) against herpes zoster for the prevention of shingles.
The EMA has accepted Optimer Pharmaceuticals' MAA for its narrow-spectrum antibiotic fidaxomicin for the treatment of Clostridium difficile infection (CDI) and for the prevention of recurrences of CDI.